DE69513832D1 - Exzitatorische aminosäure-rezeptor-antagonisten - Google Patents
Exzitatorische aminosäure-rezeptor-antagonistenInfo
- Publication number
- DE69513832D1 DE69513832D1 DE69513832T DE69513832T DE69513832D1 DE 69513832 D1 DE69513832 D1 DE 69513832D1 DE 69513832 T DE69513832 T DE 69513832T DE 69513832 T DE69513832 T DE 69513832T DE 69513832 D1 DE69513832 D1 DE 69513832D1
- Authority
- DE
- Germany
- Prior art keywords
- excitative
- amino acid
- receptor antagonists
- acid receptor
- antagonists
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C62/08—Saturated compounds containing ether groups, groups, groups, or groups
- C07C62/12—Saturated compounds containing ether groups, groups, groups, or groups polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C62/18—Saturated compounds containing keto groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C62/18—Saturated compounds containing keto groups
- C07C62/22—Saturated compounds containing keto groups polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C62/18—Saturated compounds containing keto groups
- C07C62/26—Saturated compounds containing keto groups containing singly bound oxygen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30325594A | 1994-09-08 | 1994-09-08 | |
US08/500,303 US5717109A (en) | 1994-09-08 | 1995-07-10 | Excitatory amino acid receptor antagonists |
PCT/US1995/010031 WO1996007405A1 (en) | 1994-09-08 | 1995-08-07 | Excitatory amino acid receptor antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69513832D1 true DE69513832D1 (de) | 2000-01-13 |
DE69513832T2 DE69513832T2 (de) | 2000-04-13 |
Family
ID=26973356
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69513832T Expired - Fee Related DE69513832T2 (de) | 1994-09-08 | 1995-08-07 | Exzitatorische aminosäure-rezeptor-antagonisten |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0771196B1 (de) |
JP (1) | JPH10505597A (de) |
AU (1) | AU701863B2 (de) |
CA (1) | CA2199508A1 (de) |
DE (1) | DE69513832T2 (de) |
ES (1) | ES2139928T3 (de) |
IL (1) | IL114932A0 (de) |
NZ (1) | NZ291597A (de) |
WO (1) | WO1996007405A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA969485B (en) * | 1995-11-16 | 1998-05-12 | Lilly Co Eli | Excitatory amino acid receptor antagonists. |
US5912248A (en) * | 1995-11-16 | 1999-06-15 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
US5688826A (en) * | 1995-11-16 | 1997-11-18 | Eli Lilly And Company | Excitatory amino acid derivatives |
US5824662A (en) * | 1996-09-27 | 1998-10-20 | Guilford Pharmaceuticals Inc. | Treatment of global and focal ischemia using naaladase inhibitors |
GB9621789D0 (en) * | 1996-10-18 | 1996-12-11 | Lilly Industries Ltd | Pharmaceutical compounds |
ES2131463B1 (es) | 1997-04-08 | 2000-03-01 | Lilly Sa | Derivados de ciclopropilglicina con propiedades farmaceuticas. |
DE19801647A1 (de) * | 1998-01-17 | 1999-07-22 | Bayer Ag | Substituierte beta,gamma-annellierte Lactone |
DE19801646A1 (de) | 1998-01-17 | 1999-07-22 | Bayer Ag | Substituierte alpha,beta-annellierte Butyrolactone |
DE19801648A1 (de) * | 1998-01-17 | 1999-07-22 | Bayer Ag | alpha-Substituierte Lactone |
DE19801636A1 (de) * | 1998-01-17 | 1999-07-22 | Bayer Ag | Substituierte bicyclische Lactone |
TW201632516A (zh) | 2014-12-11 | 2016-09-16 | 哈佛大學校長及研究員協會 | 細胞壞死抑制劑與相關方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1305177C (en) * | 1987-06-30 | 1992-07-14 | Yasufumi Ohfune | Carboxycyclopropylglycine and process for producing the same |
DE3740840A1 (de) * | 1987-11-27 | 1989-06-08 | Schering Ag | 2,2-difluorcyclopropylethanderivate, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel |
US5177109A (en) * | 1988-05-16 | 1993-01-05 | G. D. Searle & Co. | 2-amino-4,5-methyleneadipic acid compounds for treatment of CNS disorders |
JP2757960B2 (ja) * | 1988-10-17 | 1998-05-25 | サントリー株式会社 | (2R,3S,4S)−α−(カルボキシシクロプロピル)グリシン |
GB9325368D0 (en) * | 1993-12-10 | 1994-02-16 | Univ Bristol | Organic compounds |
-
1995
- 1995-08-07 NZ NZ291597A patent/NZ291597A/xx unknown
- 1995-08-07 CA CA002199508A patent/CA2199508A1/en not_active Abandoned
- 1995-08-07 EP EP95929416A patent/EP0771196B1/de not_active Expired - Lifetime
- 1995-08-07 DE DE69513832T patent/DE69513832T2/de not_active Expired - Fee Related
- 1995-08-07 JP JP8509494A patent/JPH10505597A/ja active Pending
- 1995-08-07 ES ES95929416T patent/ES2139928T3/es not_active Expired - Lifetime
- 1995-08-07 WO PCT/US1995/010031 patent/WO1996007405A1/en not_active Application Discontinuation
- 1995-08-07 AU AU32781/95A patent/AU701863B2/en not_active Ceased
- 1995-08-14 IL IL11493295A patent/IL114932A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IL114932A0 (en) | 1995-12-31 |
DE69513832T2 (de) | 2000-04-13 |
CA2199508A1 (en) | 1996-03-14 |
EP0771196B1 (de) | 1999-12-08 |
AU3278195A (en) | 1996-03-27 |
ES2139928T3 (es) | 2000-02-16 |
WO1996007405A1 (en) | 1996-03-14 |
AU701863B2 (en) | 1999-02-04 |
JPH10505597A (ja) | 1998-06-02 |
EP0771196A4 (de) | 1997-09-03 |
NZ291597A (en) | 1998-12-23 |
EP0771196A1 (de) | 1997-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO972016D0 (no) | Indolyl-Y-reseptorantagonister | |
DE69833073D1 (de) | CCR-3-Rezeptor-Antagonisten | |
DE69734833D1 (de) | Vitronektin rezeptor antagonisten | |
DE69812096T2 (de) | Neuropeptid y rezeptorantagonisten | |
EE9600186A (et) | Neurokiniini (tahhüülkiniini) antagonistid | |
NO944578D0 (no) | Eksitatoriske aminosyre reseptorantagonister | |
NO965608D0 (no) | Vitronectin-reseptor-antagonister | |
DK1009732T3 (da) | 1-Amino-alkylcyclohexan NMDA receptor antagonister | |
FI971685A0 (fi) | Takykiniini-antagonisteja | |
ID16742A (id) | Antagonis reseptor endotelin | |
NO950606D0 (no) | Adhesjonsreseptor-antagonister | |
ATE258548T1 (de) | Adhäsionsrezeptor-antagonisten | |
ID24726A (id) | Antagonis-antagonis reseptor trombin | |
BR9611509A (pt) | Antagonistas de receptores de aminoácidos excitativos | |
ID24162A (id) | Antagonis-antagonis reseptor vitronektin | |
DK0906294T3 (da) | Benzoxazinon-dopamin D4-receptor-antagonister | |
DE69513832T2 (de) | Exzitatorische aminosäure-rezeptor-antagonisten | |
BR9611521A (pt) | Antagonistas de receptor de aminoácido excitador | |
ZA956812B (en) | Excitatory amino acid receptor antagonists. | |
FI965116A0 (fi) | Uusia opioidipeptidiantagonisteja | |
ID22978A (id) | Antagonis reseptor endotelin | |
DE69615850D1 (de) | G-protein-gekoppelter rezeptor hnfd578 | |
BR9510060A (pt) | Receptor | |
KR970702876A (ko) | 뉴로키닌 길항제(Neurokinine (tachykinine) antagonists) | |
DE59503324D1 (de) | Adhäsionsrezeptor-Antagonisten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |